{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T02:15:28Z","timestamp":1783304128472,"version":"3.54.6"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T00:00:00Z","timestamp":1513728000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10528-017-9836-3","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T06:21:29Z","timestamp":1513750889000},"page":"176-187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Association Between APOA5 Gene Polymorphisms and Plasma Lipids in the Turkish Cypriot Population: A Possible Biomarker for Preventing Cardiovascular Diseases"],"prefix":"10.1007","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7933-2395","authenticated-orcid":false,"given":"Umut","family":"Fahrio\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmut \u00c7erkez","family":"Erg\u00f6ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"9836_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gene.2012.12.016","volume":"516","author":"CN Ferreira","year":"2013","unstructured":"Ferreira CN, Carvalho MG, Fernandes AP et al (2013) The polymorphism \u22121131T>C in apolipoprotein A5 gene is associated with dyslipidemia in Brazilian subjects. Gene 516:171\u2013175. https:\/\/doi.org\/10.1016\/j.gene.2012.12.016","journal-title":"Gene"},{"key":"9836_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/innovait\/inr119","volume-title":"Prevention of cardiovascular disease prevention of cardiovascular disease","author":"P Guidelines","year":"2007","unstructured":"Guidelines P, Risk C (2007) Prevention of cardiovascular disease prevention of cardiovascular disease. World Health Organization, Geneva. https:\/\/doi.org\/10.1093\/innovait\/inr119"},{"key":"9836_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1194\/jlr.M500343-JLR200","volume":"47","author":"U Hodoglugil","year":"2006","unstructured":"Hodoglugil U, Tanyola\u00e7 S, Williamson DW et al (2006) Apolipoprotein A-V: a potential modulator of plasma triglyceride levels in Turks. J Lipid Res 47:144\u2013153. https:\/\/doi.org\/10.1194\/jlr.M500343-JLR200","journal-title":"J Lipid Res"},{"key":"9836_CR4","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.gene.2016.07.070","volume":"592","author":"JA Hubacek","year":"2016","unstructured":"Hubacek JA (2016) Apolipoprotein A5 15 years anniversary: lessons from genetic epidemiology. Gene 592:193\u2013199. https:\/\/doi.org\/10.1016\/j.gene.2016.07.070","journal-title":"Gene"},{"key":"9836_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2217\/pgs.09.17","volume":"10","author":"JA Hubacek","year":"2009","unstructured":"Hubacek JA, Adamkova V, Prusikova M et al (2009) Impact of apolipoprotein A5 variants on statin treatment efficacy. Pharmacogenomics 10:945\u2013950. https:\/\/doi.org\/10.2217\/pgs.09.17","journal-title":"Pharmacogenomics"},{"key":"9836_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.33549\/physiolres.930546","volume":"53","author":"JA Hub\u00e1cek","year":"2004","unstructured":"Hub\u00e1cek JA, Ad\u00e1mkov\u00e1 V, Ceska R et al (2004) New variants in the apolipoprotein AV gene in individuals with extreme triglyceride levels. Physiol Res 53:225\u2013228","journal-title":"Physiol Res"},{"key":"9836_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cca.2008.12.024","volume":"402","author":"Y Jang","year":"2009","unstructured":"Jang Y, Paik JK, Hyun YJ et al (2009) The apolipoprotein A5 \u22121131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta 402:83\u201387. https:\/\/doi.org\/10.1016\/j.cca.2008.12.024","journal-title":"Clin Chim Acta"},{"key":"9836_CR8","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1093\/hmg\/ddg255","volume":"12","author":"J-T Kao","year":"2003","unstructured":"Kao J-T, Wen H-C, Chien K-L et al (2003) A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia. Hum Mol Genet 12:2533\u20132539. https:\/\/doi.org\/10.1093\/hmg\/ddg255","journal-title":"Hum Mol Genet"},{"key":"9836_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jacl.2012.06.002","volume":"7","author":"JY Kim","year":"2013","unstructured":"Kim JY, Kim OY, Paik JK et al (2013) Association of apolipoprotein A-V concentration with apolipoprotein A5 gene \u22121131T>C polymorphism and fasting triglyceride levels. J Clin Lipidol 7:94\u2013101. https:\/\/doi.org\/10.1016\/j.jacl.2012.06.002","journal-title":"J Clin Lipidol"},{"key":"9836_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1515\/CCLM.2008.161","volume":"46","author":"E Komurcu-Bayrak","year":"2008","unstructured":"Komurcu-Bayrak E, Onat A, Poda M et al (2008) Gender-modulated impact of apolipoprotein A5 gene (APOA5) \u22121131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults. Clin Chem Lab Med 46:778\u2013784. https:\/\/doi.org\/10.1515\/CCLM.2008.161","journal-title":"Clin Chem Lab Med"},{"key":"9836_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/NNR.0000000000000207","volume":"66","author":"Y-C Lin","year":"2017","unstructured":"Lin Y-C, Nunez V, Johns R, Shiao SPK (2017) APOA5 gene polymorphisms and cardiovascular diseases. Nurs Res 66:164\u2013174. https:\/\/doi.org\/10.1097\/NNR.0000000000000207","journal-title":"Nurs Res"},{"key":"9836_CR12","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.metabol.2004.11.009","volume":"54","author":"H Liu","year":"2005","unstructured":"Liu H, Zhang S, Lin J et al (2005) Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism 54:568\u2013572. https:\/\/doi.org\/10.1016\/j.metabol.2004.11.009","journal-title":"Metabolism"},{"key":"9836_CR13","doi-asserted-by":"publisher","first-page":"BC09","DOI":"10.7860\/jcdr\/2016\/19212.7895","volume":"10","author":"A Mahrooz","year":"2016","unstructured":"Mahrooz A, Zargari M, Ansari V et al (2016) Association of APOA5 gene promoter region -1131T\u00a0>\u00a0C polymorphism (rs662799) to plasma triglyceride level in patients with type 2 diabetic nephropathy. J Clin Diagnostic Res 10:BC09\u2013BC13. https:\/\/doi.org\/10.7860\/jcdr\/2016\/19212.7895","journal-title":"J Clin Diagnostic Res"},{"key":"9836_CR14","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1253\/circj.71.746","volume":"71","author":"A Matsunaga","year":"2007","unstructured":"Matsunaga A, Arishima H, Niimura H et al (2007) Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese population. Circ J 71:746\u2013752","journal-title":"Circ J"},{"key":"9836_CR15","unstructured":"Phase 3| 1000 Genomes (2017) In: 1000 Genomes. http:\/\/www.internationalgenome.org\/category\/phase-3\/ . Accessed 5 July 2017"},{"key":"9836_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2012.02.030","volume":"222","author":"BH Shirts","year":"2012","unstructured":"Shirts BH, Howard MT, Hasstedt SJ et al (2012) Vitamin D dependent effects of APOA5 polymorphisms on HDL cholesterol. Atherosclerosis 222:167\u2013174. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.02.030","journal-title":"Atherosclerosis"},{"key":"9836_CR17","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cca.2008.05.009","volume":"395","author":"MO Sousa","year":"2008","unstructured":"Sousa MO, Al\u00eda P, Pint\u00f3 X et al (2008) Interaction between APOA5 -1131T>C and APOE polymorphisms and their association with severe hypertriglyceridemia. Clin Chim Acta 395:68\u201371. https:\/\/doi.org\/10.1016\/j.cca.2008.05.009","journal-title":"Clin Chim Acta"},{"key":"9836_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1186\/s12944-016-0343-z","volume":"15","author":"Y Wang","year":"2016","unstructured":"Wang Y, Lu Z, Zhang J et al (2016) The APOA5 rs662799 polymorphism is associated with dyslipidemia and the severity of coronary heart disease in Chinese women. Lipids Health Dis 15:170. https:\/\/doi.org\/10.1186\/s12944-016-0343-z","journal-title":"Lipids Health Dis"},{"key":"9836_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1476-511X-10-140","volume":"10","author":"R-X Yin","year":"2011","unstructured":"Yin R-X, Li Y-Y, Lai C-Q (2011a) Apolipoprotein A1\/C3\/A5 haplotypes and serum lipid levels. Lipids Health Dis 10:140. https:\/\/doi.org\/10.1186\/1476-511X-10-140","journal-title":"Lipids Health Dis"},{"key":"9836_CR20","doi-asserted-by":"publisher","first-page":"e17954","DOI":"10.1371\/journal.pone.0017954","volume":"6","author":"R-X Yin","year":"2011","unstructured":"Yin R-X, Li Y-Y, Liu W-Y et al (2011b) Interactions of the apolipoprotein A5 gene polymorphisms and alcohol consumption on serum lipid levels. PLoS ONE 6:e17954. https:\/\/doi.org\/10.1371\/journal.pone.0017954","journal-title":"PLoS ONE"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10528-017-9836-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-017-9836-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-017-9836-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T02:20:23Z","timestamp":1693362023000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10528-017-9836-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["9836"],"URL":"https:\/\/doi.org\/10.1007\/s10528-017-9836-3","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]}}}